We are live on ! Find out more
WA

Winfield Associates Portfolio holdings

AUM $276M
1-Year Est. Return 15.18%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.89%
10 Year Est. Return
AUM
$176M
AUM Growth
+$12.9M
Cap. Flow
+$3.45M
Cap. Flow %
1.96%
Top 10 Hldgs %
30.08%
Holding
825
New
68
Increased
134
Reduced
132
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 8.79%
2 Consumer Discretionary 8.35%
3 Communication Services 6.83%
4 Financials 5.32%
5 Industrials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S
726
DELISTED
Sprint Corporation
S
$1K ﹤0.01%
160
TI.A
727
DELISTED
Telecom Italia 10 Svg
TI.A
$1K ﹤0.01%
165
-80
-33% -$565
ATHN
728
DELISTED
Athenahealth, Inc.
ATHN
$1K ﹤0.01%
5
PF
729
DELISTED
Pinnacle Foods, Inc.
PF
$1K ﹤0.01%
25
VR
730
DELISTED
Validus Hold Ltd
VR
$1K ﹤0.01%
10
OA
731
DELISTED
Orbital ATK, Inc.
OA
$1K ﹤0.01%
+10
New +$925
BUFF
732
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$1K ﹤0.01%
30
BIVV
733
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1K ﹤0.01%
+25
New +$1.23K
CPN
734
DELISTED
Calpine Corporation
CPN
$1K ﹤0.01%
125
CAA
735
DELISTED
CalAtlantic Group, Inc.
CAA
$1K ﹤0.01%
25
-40
-62% -$1.41K
BRCD
736
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$1K ﹤0.01%
110
PTHN
737
DELISTED
Patheon N.V.
PTHN
$1K ﹤0.01%
55
PDLI
738
DELISTED
PDL BioPharma, Inc.
PDLI
$1K ﹤0.01%
300
SBNY
739
DELISTED
Signature Bank
SBNY
$1K ﹤0.01%
10
UFS
740
DELISTED
DOMTAR CORPORATION (New)
UFS
$1K ﹤0.01%
40
LPNT
741
DELISTED
LifePoint Health, Inc.
LPNT
$1K ﹤0.01%
20
AMFW
742
DELISTED
AMEC Foster Wheeler plc
AMFW
$1K ﹤0.01%
+155
New +$909
CNCO
743
DELISTED
Cencosud S.A.
CNCO
$1K ﹤0.01%
55
CIT
744
DELISTED
CIT Group Inc.
CIT
$1K ﹤0.01%
30
SPN
745
DELISTED
Superior Energy Services, Inc.
SPN
$1K ﹤0.01%
5
TCF
746
DELISTED
TCF Financial Corporation
TCF
$1K ﹤0.01%
50
AAN.A
747
DELISTED
The Aaron's Company Inc Class A
AAN.A
$1K ﹤0.01%
20
ALNY icon
748
Alnylam Pharmaceuticals
ALNY
$37.2B
$0 ﹤0.01%
5
-10
-67% -$462
AMD icon
749
Advanced Micro Devices
AMD
$807B
$0 ﹤0.01%
+10
New +$127
ANIX icon
750
Anixa Biosciences
ANIX
$118M
$0 ﹤0.01%
80

Similar funds

Winfield Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Winfield Associates held 825 positions worth $176M, up 7.9% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Winfield Associates's Q1 2017 filing shows 68 new, 134 increased, 132 reduced and 48 closed positions. Its largest new stake was Nucor: 6,600 shares worth $394K. The largest sale was Mobileye N.V., an estimated $788K.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, up from 8.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Winfield Associates's largest Q1 2017 buy was Nucor: 6,600 shares worth $394K.
  • Winfield Associates added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $755K increase.
  • Winfield Associates's biggest Q1 2017 reduction was iShares Biotechnology ETF, cutting an estimated $771K.
  • Winfield Associates fully exited Mobileye N.V. in Q1 2017, selling an estimated $788K.
  • Winfield Associates's ten largest holdings make up 30% of its $176M portfolio in Q1 2017.
  • Winfield Associates opened 68 new positions and closed 48 in Q1 2017.
  • Winfield Associates's portfolio value rose 7.9% quarter-over-quarter to $176M.

Based on Winfield Associates's 13F filing for Q1 2017, filed 10 May 2017.